Xvivo Perfusion AB

XVIVO.ST · Moat type: UNBESTIMMT

MoatScore

3/10

Fair Value

32 SEK (≈ 3.31 USD)

Margin of Safety

-672.6 %

Rating

SCHWACH

Xvivo Perfusion develops and distributes systems and solutions for machine perfusion of donor organs (primarily lung, heart, liver), which improve the durability and quality of transplant organs and thereby increase the number of usable organs.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.